EBM Technologies Incorporated (TPEX:8409)
Taiwan · Delayed Price · Currency is TWD 20.70
+0.45 (2.22%)
At close: Feb 11, 2026
EBM Technologies Market Cap
EBM Technologies has a market cap or net worth of 662.4 million as of February 13, 2026. Its market cap has decreased by -13.57% in one year.
Market Cap
662.40M
Enterprise Value
616.86M
Revenue
348.42M
Ranking
n/a
PE Ratio
14.34
Stock Price
20.70
Market Cap Chart
Since April 13, 2010, EBM Technologies's market cap has decreased from 882.35M to 662.40M, a decrease of -24.93%. That is a compound annual growth rate of -1.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 662.40M | -4.83% |
| Dec 31, 2025 | 696.00M | -7.45% |
| Dec 31, 2024 | 752.00M | -6.00% |
| Dec 29, 2023 | 800.00M | 31.93% |
| Dec 30, 2022 | 606.40M | 6.16% |
| Dec 30, 2021 | 571.20M | 11.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 268.14B |
| Caliway Biopharmaceuticals | 248.00B |
| Lotus Pharmaceutical | 76.92B |
| Heron Neutron Medical | 74.10B |
| BioLASCO Taiwan | 761.96M |
| General Biologicals | 739.02M |
| Sofiva Genomics | 735.26M |
| Bioray Biotech | 727.80M |